-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Buy on Accendra Health, Lowers Price Target to $4.5

Benzinga·07/24/2026 19:18:44
Listen to the news
Citigroup analyst Daniel Grosslight maintains Accendra Health (NYSE:ACH) with a Buy and lowers the price target from $5 to $4.5.